Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Paracrine signaling via secretion of trophic factors refers to a mechanism of cell communication where cells secrete molecules—including growth factors, cytokines, neurotrophins, and other signaling proteins—into their immediate environment, causing nearby cells to undergo changes in behavior, fate, or function[1][3][4]. These molecules act locally (on neighboring cells) rather than distantly (as in endocrine signaling), mediating processes such as development, tissue repair, angiogenesis, and response to injury. The effects of paracrine signaling are mediated by the binding of secreted trophic factors to specific receptors on adjacent cells, often triggering complex intracellular pathways such as receptor tyrosine kinase activation and downstream transcriptional responses[1][2]. Major protein families involved include fibroblast growth factors, Hedgehog proteins, Wnt proteins, and the TGF-β superfamily[1][4]. In a therapeutic context, clinical strategies do not target "paracrine signaling" as a whole, but instead focus on specific factor-receptor pairs within these pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Paracrine signaling via secretion of trophic factors.